| BSE Code | Company | Start Date | Purpose |
|---|---|---|---|
| 524576 | Vivid Global Vivid Global Industries Ltd | 04-Nov-2026 | Vivid Global Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 inter alia to consider and approve Unaudited Financial Results for the quarter and half year ended 30th September 2025 along with Limited Review Report thereon. 2.To take Note of Compliances on SEBI (LODR) Regulations 2015 for the quarter ended 30th September 2026. 3.Any other items with t6e permission of Chairman. |
| 524614 | IEL IEL Ltd | 04-Nov-2026 | IEL Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve 1. Un-Audited Standalone Financial Results of the Company for the Quarter and Half Year ended 30th September 2026. 2. Any other matter with the permission of Chair. |
| 524632 | Shukra Pharma. Shukra Pharmaceuticals Ltd | 04-Nov-2026 | Quarterly Results The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 (As per BSE Announcement dated on: 23.10.2026) |
| 524804 | Aurobindo Pharma Aurobindo Pharma Ltd | 04-Nov-2026 | Aurobindo Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on November 4 2026 inter alia to consider and approve Standalone & Consolidated Unaudited Financial Results of the Company for the second quarter and half year ended September 30 2026 and Payment of Interim Dividend if any for the financial year 2026-27. |
| 524820 | Panama Petrochem Panama Petrochem Ltd | 04-Nov-2026 | Panama Petrochem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 inter alia to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter/half year ended September 30 2026. |
| 526251 | Mid East Port. Mid East Portfolio Management Ltd | 04-Nov-2026 | Mid East Portfolio Management Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 inter alia to consider and approve 1. To consider approve and take on record the Unaudited Standalone Financial Result of the Company for the Second Quarter and Half Year ended on 30th September 2026 as per Regulation 33 of the SEBI (LODR) Regulation 2015; 2. Such Other agendas as may be considered necessary with the permission of the chair. |
| 524091 | Carysil Carysil Ltd | 04-Nov-2026 | Carysil Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and half year ended September 30, 2026 |
| 523716 | Ashiana Housing Ashiana Housing Ltd | 04-Nov-2026 | Ashiana Housing Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 inter alia to consider and approve unaudited (Standalone and Consolidated) Financial Results for the quarter and half-year ended on 30th September 2026 apart from transacting other routine items |
| 524404 | Marksans Pharma Marksans Pharma Ltd | 04-Nov-2026 | Marksans Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 inter alia to consider and approve Unaudited Financial Results of the Company (both Standalone and Consolidated) for the quarter and half year ended September 30 2026 |
| 523405 | JM Financial JM Financial Ltd | 04-Nov-2026 | JM Financial Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the second quarter and half year ended September 30 2026. |
Old Backoffice
Data available till FY 2024-25 (Historical)
New Backoffice
Data From FY 2025-26 onwards (Latest)
